Clinical Trial Update: Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating Dextran as a plasma expander for decompensated liver cirrhosis with acute kidney injury have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Kidney Injury

Drugs mentioned

• Dextran (Dextran)

Snippet

Sponsor: Ramathibodi Hospital | Conditions: Cirrhosis, Liver, AKI | Phase 2, Phase 3 | Status: COMPLETED